
ONX-0914
CAS No. 960374-59-8
ONX-0914( PR-957 | ONX 0914 | ONX0914 | PR957 | PR 957 )
Catalog No. M16857 CAS No. 960374-59-8
ONX-0914 (PR-957) is a potent, selective inhibitor of the chymotrypsin-like subunit of immunoproteasome LMP7 with IC80 <100 nM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 110 | In Stock |
![]() ![]() |
10MG | 177 | In Stock |
![]() ![]() |
25MG | 299 | In Stock |
![]() ![]() |
50MG | 448 | In Stock |
![]() ![]() |
100MG | Get Quote | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameONX-0914
-
NoteResearch use only, not for human use.
-
Brief DescriptionONX-0914 (PR-957) is a potent, selective inhibitor of the chymotrypsin-like subunit of immunoproteasome LMP7 with IC80 <100 nM.
-
DescriptionONX-0914 (PR-957) is a potent, selective inhibitor of the chymotrypsin-like subunit of immunoproteasome LMP7 with IC80 <100 nM, 20- to 40-fold more selective over β5 or LMP2; blocks presentation of LMP7-specific, MHC-I-restricted antigens in vitro and in vivo, blocks production of interleukin-23 (IL-23) by activated monocytes and interferon-gamma and IL-2 by T cells; reverses signs of disease and results in reductions in cellular infiltration, cytokine production and autoantibody levels in experimental arthritis models.
-
In Vitro——
-
In VivoAnimal Model:Collagen antibody-induced arthritis (CAIA, Arthritis was induced in BALB/c mice with antibodies specific for type II collagen (mAb) and endotoxin)Dosage:2, 6 or 10 mg per kg body weight Administration:I.v.; treated on days 4, 6 and 8 Result:Blocked disease progression in a dose-dependent manner and completely ameliorated visible signs of disease at the highest dose.
-
SynonymsPR-957 | ONX 0914 | ONX0914 | PR957 | PR 957
-
PathwayProteasome/Ubiquitin
-
TargetProteasome
-
RecptorLMP7
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number960374-59-8
-
Formula Weight580.6719
-
Molecular FormulaC31H40N4O7
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 35 mg/mL
-
SMILESO=C(N[C@@H](CC1=CC=CC=C1)C([C@]2(C)OC2)=O)[C@@H](NC([C@@H](NC(CN3CCOCC3)=O)C)=O)CC4=CC=C(OC)C=C4
-
Chemical NameL-Tyrosinamide, N-[2-(4-morpholinyl)acetyl]-L-alanyl-O-methyl-N-[(1S)-2-[(2R)-2-methyl-2-oxiranyl]-2-oxo-1-(phenylmethyl)ethyl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Muchamuel T, et al. Nat Med. 2009 Jul;15(7):781-7.
2. Basler M, et al. J Immunol. 2010 Jul 1;185(1):634-41.
3. Ichikawa HT, et al. Arthritis Rheum. 2012 Feb;64(2):493-503.
4. Verbrugge SE, et al. J Pharmacol Exp Ther. 2012 Apr;341(1):174-82.
molnova catalog



related products
-
ML 604440
ML 604440 (ML604440, ML-604440) is a potent, specific and cell permeable proteasome β1i (LMP2) subunit inhibitor.
-
1G244
1G244 is an inhibitor of DPP8/9 with antiatherosclerotic and antimyeloma properties. 1G244 had the IC50 values of 14 and 53 nM against DPP8 and DPP9, and The Ki values for 1G244 were 0.9 and 4.2 nM for DPP8 and DPP9
-
ONX-0914
ONX-0914 (PR-957) is a potent, selective inhibitor of the chymotrypsin-like subunit of immunoproteasome LMP7 with IC80 <100 nM.